Related Experiment Video

Updated: Jun 6, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

No evidence of impaired endothelial function or altered inflammatory state in patients with familial

Anders Hovland1, Inger Aagnes, Ole-Lars Brekke

  • 1Coronary Care Unit, Department of Internal Medicine, Nordland Hospital, Prinsens gate, N-8092 Bodø, Norway. anders.w.hovland@gmail.com

Journal of Clinical Lipidology
|December 3, 2010
PubMed

Insights

Familial hypercholesterolemia (FH) patients on statins showed no differences in endothelial function or inflammatory markers compared to healthy individuals. This suggests statin therapy may normalize these cardiovascular risk factors in FH.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Research
  • Biomarker Analysis

Background:

  • Familial hypercholesterolemia (FH) significantly elevates the risk of premature atherosclerosis.
  • Inflammation and endothelial dysfunction are key contributors to FH-related cardiovascular events.

Purpose of the Study:

  • To compare inflammatory cytokines and endothelial function in statin-treated FH patients versus healthy controls.
  • To investigate the impact of statin therapy on cardiovascular risk markers in FH.

Main Methods:

  • Endothelial function assessed using the Endo-PAT® system to measure reactive hyperemia index (RHI).
  • Analyzed 27 inflammatory biomarkers and standard laboratory tests from fasting blood samples.
  • Included 14 FH patients on statins and 11 healthy control participants.

Main Results:

  • No significant differences in age, weight, blood pressure, or BMI between FH and control groups.
  • Similar endothelial function (RHI) and levels of various inflammatory markers (TNF-α, IL-1β, IL-6, hs-CRP, etc.) were observed.
  • Lipid profiles, apolipoproteins, homocysteine, HbA1c, platelets, and fibrinogen also showed no significant intergroup differences.

Conclusions:

  • Statin treatment in FH patients did not result in statistically significant differences in endothelial function or inflammatory biomarkers compared to healthy controls.
  • Assessed endothelial function and inflammatory status appear normalized in FH patients on statins.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Inflammation01:38

Inflammation

Overview